These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25148442)

  • 1. Managing hypertension in patients with chronic kidney disease.
    Zuber K; Gilmartin C; Davis J
    JAAPA; 2014 Sep; 27(9):37-46. PubMed ID: 25148442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension Management in Transition: From CKD to ESRD.
    Valika A; Peixoto AJ
    Adv Chronic Kidney Dis; 2016 Jul; 23(4):255-61. PubMed ID: 27324679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic Issues in treating hypertension in CKD.
    Sica DA
    Adv Chronic Kidney Dis; 2011 Jan; 18(1):42-7. PubMed ID: 21224029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy in hypertension.
    Gorostidi M; de la Sierra A
    Adv Ther; 2013 Apr; 30(4):320-36. PubMed ID: 23553510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Pharmacology of Antihypertensive Therapy for the Treatment of Hypertension in CKD.
    Sinha AD; Agarwal R
    Clin J Am Soc Nephrol; 2019 May; 14(5):757-764. PubMed ID: 30425103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Blocker withdrawal is preferable for accurate interpretation of the aldosterone-renin ratio in chronically treated hypertension.
    Browne GA; Griffin TP; O'Shea PM; Dennedy MC
    Clin Endocrinol (Oxf); 2016 Mar; 84(3):325-31. PubMed ID: 26300226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension control in chronic kidney disease: don't miss the forest for the trees.
    Ong HT; Ong LM; Ho JJ
    Med J Malaysia; 2012 Aug; 67(4):359-62. PubMed ID: 23082441
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of Antihypertensive Agents and Association With Risk of Adverse Outcomes in Chronic Kidney Disease: Focus on Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers.
    Ku E; McCulloch CE; Vittinghoff E; Lin F; Johansen KL
    J Am Heart Assoc; 2018 Oct; 7(19):e009992. PubMed ID: 30371331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacology of modern antihypertensive agents and their interaction with alpha-adrenoceptor antagonists.
    Narayan P; Man In't Veld AJ
    Br J Urol; 1998 Mar; 81 Suppl 1():6-16; discussion 64-6. PubMed ID: 9589011
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypertension. Medication update.
    Collard CL
    South Med J; 2001 Nov; 94(11):1065-70. PubMed ID: 11780675
    [No Abstract]   [Full Text] [Related]  

  • 11. Managing hypertension in chronic renal disease.
    Faubert PF; Porush JG
    Geriatrics; 1987 Jan; 42(1):49-51, 55-8. PubMed ID: 2879773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current trends in the therapy for hypertension, 1985.
    Ryan C
    Compr Ther; 1985 Oct; 11(10):22-7. PubMed ID: 2865033
    [No Abstract]   [Full Text] [Related]  

  • 13. Development and trends in the drug treatment of essential hypertension.
    van Zwieten PA
    J Hypertens Suppl; 1992 Dec; 10(7):S1-12. PubMed ID: 1363322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypertension in patients with heart failure].
    Takekoshi N; Asaji T; Tada N
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():478-83. PubMed ID: 15171419
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypertension--new drug therapies. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure.
    Solomon J
    RN; 1994 Jan; 57(1):26-32; quiz 33. PubMed ID: 7905659
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of calcium channel blockers comparing to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis.
    Lin YC; Lin JW; Wu MS; Chen KC; Peng CC; Kang YN
    PLoS One; 2017; 12(12):e0188975. PubMed ID: 29240784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia.
    Hsu TW; Liu JS; Hung SC; Kuo KL; Chang YK; Chen YC; Hsu CC; Tarng DC
    JAMA Intern Med; 2014 Mar; 174(3):347-54. PubMed ID: 24343093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical trials on protective efficacy of antihypertensive agents for organ damage due to diabetes mellitus complicated with hypertension].
    Higashiura K
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():623-7. PubMed ID: 15171446
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of antihypertensive drugs on chronic kidney disease: a comprehensive review.
    Ptinopoulou AG; Pikilidou MI; Lasaridis AN
    Hypertens Res; 2013 Feb; 36(2):91-101. PubMed ID: 23051659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 50 years of thiazides: should thiazide diuretics be considered third-line hypertension treatment?
    Brown A; Captain B
    Am J Ther; 2011 Nov; 18(6):e244-54. PubMed ID: 21436766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.